Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Google has announced that using its newly incorporated Lyria 3 model, Gemini users will be able to generate 30-second music tracks based on a prompt, or remix an existing track to their liking. The ...

The streaming giant is critical for legacy catalogs, but it's plagued by unofficial uploads and poor-quality bootlegs. Here's how to cut through the noise. In today’s music business, the race to ...